AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 142 filers reported holding AMICUS THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 0.40 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $17,422,000 | -22.6% | 1,440,999 | -0.0% | 0.05% | -27.3% |
| Q2 2018 | $22,516,000 | -0.6% | 1,441,462 | -4.3% | 0.07% | -1.5% |
| Q1 2018 | $22,662,000 | -41.1% | 1,506,785 | -45.2% | 0.07% | -42.2% |
| Q3 2015 | $38,452,000 | +169.9% | 2,748,548 | +172.9% | 0.12% | +205.3% |
| Q2 2015 | $14,249,000 | +89.9% | 1,007,002 | +46.0% | 0.04% | +100.0% |
| Q1 2015 | $7,504,000 | – | 689,719 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |